http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103127171-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf415258683635c3e869f8fdd14bb250
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
filingDate 2013-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ec663e637fcfe0c77324d6324a758b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14feab3619cc78d1e0fe653c3f410cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a53311cf9966978acd9d498a77dead3
publicationDate 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103127171-B
titleOfInvention Tablet pharmaceutical composition containing neutral phosphate
abstract The invention relates to a tablet pharmaceutical composition containing neutral phosphate, which comprises phosphoric acid metal ion salt, polyvinylpyrrolidone, sodium carboxymethyl starch, talcum powder and optional flavoring agent. The tablet pharmaceutical composition can be tablets, and the tablets present neutrality and can be used for supplementing phosphorus for human body so that the balance of phosphorus in human body can be maintained. The tablet pharmaceutical composition has good pharmacy performance.
priorityDate 2013-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10990876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450006894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451804708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453492134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383

Total number of triples: 51.